#Precigen to showcase rapid commercialization momentum and growing market adoption of first-and-only FDA-approved therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference.  View press release: bit.ly/jpm26-momentum #JPM26 #JPM2026

#Precigen to participate in upcoming virtual fireside chats hosted by Cantor and H.C. Wainwright to discuss the recent approval of the first and only FDA-approved therapy for the treatment of adults with RRP. View event details: bit.ly/41VSmMT

#Precigen is proud to announce the first and only @US_FDA-approved therapy for the treatment of adults with #RecurrentRespiratoryPapillomatosis. View press release: bit.ly/papzimeos-FDAapproval

Join us on Wednesday, September 18 for a fireside chat with @Precigen's President and CEO, Helen Sabzevari, at the 2024 Cantor Global Healthcare Conference. View details and register for the webcast: bit.ly/3LqNK9i #CantorHCC

@Precigen reports second quarter / first half 2024 financial results and business updates. View press release and join our conference call today at 4:30pm ET: bit.ly/3yGJAae $PGEN

Join #Precigen on Wednesday, August 14, 2024 at 4:30 PM ET for a conference call to discuss second quarter and first half 2024 financial results. View details: bit.ly/3LqNK9i $PGEN

#ICYMI: Watch the replay and check out photos from the first #RRPAwarenessDay. Thank you to our patient and caregiver panelists, our co-hosts at RRPF, @theNCI panelists, @MarkWarner, @iamwesmoore and all who viewed the event! rrpawareness.org #GivingVoicetoInspireChange

We had an amazing time at our inaugural #RRPAwarenessDay. Together, we are shaping a hopeful and positive future for those impacted by RRP. Watch the #RRPAwarenessDay co-hosts share their thoughts on what they hope we achieved for RRP patients today. #GivingVoicetoInspireChange